Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jingmen Shangqing Wan for recurrent oral ulcer
CTR20132444Phase 2Completed
- Sponsor
- Hubei Qijin Pharmaceutical
- Start
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Jingmen Shangqing Pill in aphthosis (RAS), sponsored by Hubei Qijin Pharmaceutical. Started Feb 2014; status: completed.
02
Drugs
Jingmen Shangqing Pill
03
Conditions
aphthosis (RAS)
Beyond the preview
Go deeper on CTR20132444.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132444.